For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
National Review
The Return of the Cadillac Tax?
Like the phoenix, a key piece of the Affordable Care Act has risen from the ashes, resurrected, believe it or not, by the Republican Study Committee…
Blog
Free the Economy podcast: Paying for organs with Pete Jaworski
In this week’s episode we cover the future of AI and employment, why we shouldn’t trust Chinese economic statistics, and how the…
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
Search Posts
Op-Eds
A Crashing Failure: The Stupid Tragedy of CAFE
Provided courtesy of www.nationalreview.com/ If the National Academy of Sciences discovered that a certain chemical was killing several…
Citation
Resort to False Fuel Savings
Op-Eds
Dangerous GM Gets Off Scot-Free
Conko and Miller Op-Ed in The Wall Street Journal Europe<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> …
Products
Life, Liberty, And Cell Phones
From the August 2001 Edition of CEI Update A car speeds down a busy highway, zigzagging unpredictably from lane to…
Op-Eds
Cutting Regulation From the EPA: Gene-splicing Policy Should Be Excised
Miller Op-Ed in The Washington TImes Miller Op-Ed in The Washington Times A persistent criticism of the…
Op-Eds
Plants Are Not Pesticides
Miller Op-Ed in The National Post<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> A New U.S. EPA…